Philip Morris
Epa Comments on Crs Draft 'environmental Tobacco Smoke and Lung Cancer Risk'
Fields
- Type
- REPT, REPORT, OTHER
- Area
- WORLDWIDE REG AFFAIRS/LIBRARY
- Site
- N403
- Characteristic
- ATCH, ATTACHMENTS MISSING
- Document File
- 2048280245/2048280868/Ets Congressional Research Svce. (Crs)@ 2048280246/2048280600/Ets Crs Compilation 940000 - 960000
- Master ID
- 2048280248/0599
Related Documents:- 2048280248-0249 Congressional Research Service Reports on Ets and Lung Cancer
- 2048280250 1
- 2048280251-0329 Crs Report for Congress Environmental Tobacco Smoke and Lung Cancer Risk
- 2048280330 2
- 2048280331-0332
- 2048280333 Ford Calls for Reopening of OSHA Hearings on Smoking Bans
- 2048280334 Epa / OSHA Findings on Passive Smoking
- 2048280335
- 2048280336-0337 Proposed Ban on Smoking in the Workplace
- 2048280338 3
- 2048280339 Philip Morris Statement on the Congressional Research Service Report on 'environmental Tobacco Smoke and Lung Cancer Risk'
- 2048280340-0341 Overview of the Crs Report on Ets and Lung Cancer Risk
- 2048280342 3
- 2048280343 A Conversation with Mike Wallace
- 2048280344 Second Smoke's Dangers Doubted Report Critical of Epa, OSHA
- 2048280345 Editorial Up in Smoke
- 2048280346-0347 Epa Watch
- 2048280348
- 2048280348A-0349 Study Prompts Call for OSHA to Reopen Hearings on Rule Over Secondhand Smoke
- 2048280349A Study Prompts Call for OSHA to Reopen Hearings on Rule Over Secondhand Smoke
- 2048280350 Sinister Smoke? Prove It
- 2048280351 Nra Backs Report Questioning Epa Smoking Study
- 2048280352-0353 Secondhand Smoke Danger Relies on Wisps of Evidence 9500029108
- 2048280354-0355 Indoor Air Review
- 2048280356-0358 Anthology of 950000's Environmental Myths
- 2048280359-0360 Doctors and Scientists in the Anti-Smoking Crusade Stub Out the Facts
- 2048280361 Scientific Proof Eludes Those Who Damn Second-Hand Smoke
- 2048280362-0363 New Congressional Study Shows Minimal Health Effects From Environmental Tobacco Smoke
- 2048280364 Cato Environmental Expert Available to Comment on Secondhand Smoke Study
- 2048280365 Cancer Risks for Thee, But Not for Me
- 2048280366-0367 Here's News
- 2048280368 Report on Tobacco Smoke Is Good News for Farmers
- 2048280369-0370 Nam Calls on OSHA to Revise Stringent Air Quality Standards Following Crs Study of Second Hand Smoke
- 2048280371 New Study Questions OSHA Attack on Environmental Tobacco Smoke
- 2048280372-0373 Assumptions on Second-Hand Smoke Not Holding Up Under Scientific Scrutiny
- 2048280374-0375 Selected Quotes From Crs Report on Ets
- 2048280376 New Study Demonstrates OSHA Excesses on Regulations
- 2048280377 5
- 2048280378-0381
- 2048280382-0384
- 2048280404-0406
- 2048280407 Comments on the Crs Report 'environmental Tobacco Smoke and Lung Cancer Risk'
- 2048280408 6
- 2048280409-0412
- 2048280413 7
- 2048280414 Even Congressional Research Service Now Reluctantly Admits:Tobacco Smoke Causes High Levels of Cancer in Nonsmokers
- 2048280415 Congressional Research Service Also Concludes Tobacco Smoke Causes Lung Cancer in Nonsmokers
- 2048280416 Crs Says Tobacco Smoke Kills Nonsmokers But Overall Report Is Flawed and Misleading
- 2048280417 Letters Being Near A Lit Cigarette Has Risks - Whether You're Smoking It or Not
- 2048280418 8
- 2048280419-0488 Crs Report for Congress Cigarette Taxes to Fund Health Care Reform: An Economic Analysis
- 2048280489 9
- 2048280490-0496 Discussion of Source of Claims of 50,000 Deaths From Passive Smoking
- 2048280497 10
- 2048280498-0519 Hearing to Discuss the Possible Health Effects to Non-Smokers of Environmental Tobacco Smoke Wednesday, 940511 9:30 A.M. Hart Senate Office Building, Rm. 216
- 2048280520 11
- 2048280521-0536 Statement of Dr. Jane G. Gravelle Senior Specialist in Economic Policy and Dennis Zimmerman Specialist in Public Finance Congressional Research Service Before the Subcommittee on Clean Air and Nuclear Regulation Committee on Environment and Public Works United States Senate 940511 on Environmental Tobacco Smoke
- 2048280537 12
- 2048280538-0553 Cigarette Taxes to Fund Health Care Reform
- 2048280554 13
- 2048280555-0557
- 2048280558-0572
- 2048280573 14
- 2048280574-0582 Comments on Congressional Research Service Assessment of the Health Risks of Environmental Tobacco Smoke
- 2048280583 15
- 2048280584-0598 Comments on the Workshop Draft of Environmental Tobacco Smoke and Lung Cancer
- 2048280599
- Litigation
- Stmn/Produced
- Named Person
- Alavanja
- Crawford
- Fontham
- Friedman
- Glantz
- Gravelle
- Jenkins
- Lemarchand
- Mulhollan, D.
- Palmer
- Parmley
- Parrish
- Riboli
- Wells
- Willett
- Zimmerman
- Crawford
- Request
- Stmn/R1-048
- Named Organization
- Congress
- Crs
- Dept of Labor
- Epa, Environmental Protection Agency
- Hhs, Dept of Health and Human Services
- Jama
- Jnci
- Natl Research Council
- NCI, Natl Cancer Inst
- Nejm
- Niosh, Natl Inst for Occupational Safety & Health
- Oak Ridge
- OSHA, Occupational Safety & Health Administration
- RJR, R.J.Reynolds
- Sab
- Crs
- Date Loaded
- 05 Jun 1998
- UCSF Legacy ID
- bjq92e00
Document Images
1
I
I
EPA COI4IEN'PS ON CRS DRA.FT "ENVIRONMENTAL TOBACCO SMOKE
CANCER RISR" (June 5, 1995)
Gaaraau co1oasarrs
AND LUNG
1. The Draft has no stated purposa-and seems not to be dealing
with any current or proposed legislation. Without a stated
purpose, review comments become difficult. If the purpose is
to provide a de novo CRS analysis of ETS and lung cancer
hazard or risk, the analysis lacks rigor. If the purpose is
to provide Congress with a better CRS review of the lung
cancer section of the EPA Report (on the Respiratory Health
$ffacts of Passive Smoking) than was done in the previous CRS
report, then this should be stated. If the purpose is to
provide Congress with an analysis of the OSF1A proposed Indoor
Air Quality Rule on E'TS, then the Draft should have stated
*this (and CRS should have provided comments to the OSAA
docket). If ths purpose is to provide an uncritical analysis
of tobacco industry vs. Govarn=ent/scientific and public
health community positions, then this should be stated and
arguments should be identified by source. Currently,
-xquments presented by industry and their consultants are not
properly identified. Without a stated purpose, we will assume
that the purpose of this Draft is to do an independent
analysis of ETS and lung cancer risk, giving arguments from
both sides equal a priorl credence and relyinq on the author's
analytical abilities to arrive at an unbiased judgement.
2. The Draft's literature rsview is inadequate, especially with
respect to ETS exposure. For the exposura assesssant, too
much weight is given to the unpublished Jenkins at ai. U.S.
data and the 13 country Riboli et al. results, which include
non-U.S. populations, while other published U.S. results are
not reviewed. Faulty use of both these studies in the Draft's
risk assessment leads to erroneous conclusions, especially
about the relativs home vs. workplace 8TS sxposurss, and
subsequent risk estimates.
3. The Draft's analysis of lung cancer risk, mostly limited to
three recent studies, loses perspective by failinq to show the
consistency of results in thirty other studies from different
countries. Since bias is mostly a function of study design,
and potential confounding factors for lung cancer are often
cultural or dietary, failure to acknowledge these consistent
increases from many studies in eight different countries could
lead to the Draft's overstating the asount of uncertainty.
For example, the amount of smoker sisclassification bias
necessary to explain the observed increased lunq cancer risks
in Japan and Greece is over 50%, far higher than has aver been
hypothesized.
6 ra
1
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
4. The Draft takes the potential upward bias of smoker-status
sisclassification as truth and as if it is the only
operational bias, and then seeks to determine the amount of
smoker status misclassification necessary to observe the
increased lung cancer risk in one study. The Draft's method
is improper for several reasons, detailed within our specific
comments, and leads to the incorrect conclusion that "only a
small number of case group members would need to be
misclassified as never smokers to account for all the measured
risk" (CRS-2). The Draft's approach in this area leads one to
be suspicious of its intent (see also next point).
5. There is almost no consideration of the substantial downward
bias on the lung cancer relative risk (RR) estimates from two
types of exposure misclassification. The first type occurs,
because people with nonsmokinq spouses are still exposed to
other sources of BTS and there is no clean "unexposed" group.
The second type occurs because some people whose spouses smoke
may not actually be exposed to auch of the smoke; e.g., some
spouses who smoke a lox say not smoke such at home. Analyses
of lung cancer risk from workplace ETS exposure are generally
prone to even greater exposure misclassification than the
spousal smoking analyses. Failure to consider these well
established downward biases for 8TS could lead to erroneous
conclusions, especially ons of a possible threshold. 6. The quantitative risk assessment methodology
used to estimate
the lung cancer risk is seriously flawed. First, there is no
sound rationale for the Draft assuming an effective threshold
at exposure levels of practical concern. The reliance on
portions of two studies as total support for an effective
threshold, iqnorinq the exposure-rasponse results from other
studies, several of which report increased risks from lower
exposures (see EPA Report Table 5-11), suqqests, at worst,
selective biased use of data. At best, the Draft ascribes too
much sensitivity and precision to the low exposure region of
the two epidemiology studies, especially qiven the exposure
misclassification problems in all t$ess studies. Furthermore,
the methodology used allows no margin for variability in the
human populatioa or measurement error. In addition, the
results presented rely on a faulty exposure assessment (see
specific comments below).
7. Appendi= C - While the EPA has no official position on the
risk of cardiovascular disease (CVD) from ETS, the CRS
analysis presented in Appendix C is cospletely inad:quate. In
addition, it is unclear why heart disease is beinq included in
a report entitled "Environmental tobacco smoke and lung cancer
risk". If the Draft is intended to be more comprehensive than
a review of only lunq cancer, it should acknowledge that there
are also other health effects attributable to ETS, including
noncancer respiratory disorders, especially in children.
w v
2 CO
N
. . ~
I

8PECI?IC COIO[EI1Tf
OvQrviow
1. The EPA does not agree with the suggestion that its approach
to assessing the lung cancer risk in its 1992 Passive Smoking
Repoit "may be misleading" or the claim that "it appears that
any risk which aay be present is concentrated in a relatively
small portion of that (the adult nonsmoking] population" (C1tS-
1). The EPA's approach was reviewed in public session by
independent scientific experts in the field, who concurred in
the EP71's methodology (See attached SAB Report). The EPA had
already sent these SAB comments to the CRS, along with the
EPA's review of the previous CRS report. A responsible CR.S
approach would be to acknowledge the degree of concurrence the
EPA report has received, rather than to simply pejoratively
state that "it may be misleading".
2. Furthermore, there is no support for the Draft's claim that
the rasainder (not exposed to ETS at home) of the nonsmoking
population would be "at a minisua, 20 times less likely to be
at risk" (CRS-1). This conclusion, based on looking at parts
of two lung cancer studies and one exposure study instead of
the whole body of evidence suggests a conclusion in search ait
data. This selection of data is exactly what, on the very
next page, the Draft accuses OSHA of doing, "OSHA based its
risk assessment on one such estimate, which indicated an
increased risk, and disregarded the remaining estimates which
found no overall association between workplace exposure and
lung cancer." In short, the methodology used by the Draft to
generate its lung cancer death estimates is seriously flawed
(CRS-i). (See our specific comaents on the dose-response
section).
3. The overview of "sources of uncertainty" (CRS-2) omits
exposure misclassification, a major sourc. of downward bias.
The EPA agrees with the conclusion that potential confounders
cannot explain the observed increases in RR. However, the
Agency does not support the conclusion that smoker
misclassification bias could be responsible. The EPA Report
actually corrects each of thirty individual studies for
potential smoker-status misclassification bias bsL= doing
specific analyses. (See other coments on dose-response
section).
4. Regarding the overview of "occupational risk (CRS-2), the
Draft's conclusion that "residential and other non-workplace
exposure tends to exceed workplace exposure by a factor of 4
to 6" is based on faulty comparisons in the Jenkins at al
study and is incorrect. A proper analysis of that study will
reveal that workplace ETS levels where there are no smoking
restrictions'are higher on average, as well as for 80th and
3
I
I
I
I
I
~
I
I
I
I
I
I
I
I
I
I
I

I
I
I
I
I
~
95th percantilss, than are smoker-occupied hoae ETS levels.
Even if workplace ETS exposures were on averag. slightly lowar
than smoker-occupied residential exposures, this does not
preclude sany exposed workers from being at increased lung
cancer risk.
5. Regarding the overview of "biological and chemical issuss"
(CRS-2),
difficult, although measurements of ETS concentration are
the EPA concluded that nicotine is generally a good
marker for ETS exposure (1992 BEPA report, Chapter 3).
6. The concluding statement (CRS-3) that "thara raaains
considerable uncertainty about the biological processes
linking ETS to possible onset of lung cancer" is specious; the
same claim could be made of active smoking or asbestos, yet
- there is no doubt that they cause lung cancer.
, Introduction
, 1. The HPA, objects to tha.Draft's claim (CRS-5) that "whil (th.
EPA report] has received support from the public health
community, it has been criticized on scientific grounds". In
fact, the EPA report has received support from the public
~ health community and from the larger scientific coaiunitv
based on its scientific marit. The Draft should acknowlsdqs
that the EPA's conclusions are very similar to those of the
' 1986 report of ths National Research Council of the National
, Academy of Scianc.s, a non-qovarnmental body of the Nations
most prestigious scientists, certainly part of the scientific
community. Similar conclusions in both the 1986 Surgeon
~ Gane.ral ls and the 1991 NIOSH Reports have been authored by
scientific axp.rts and received extensive review before
release. Also, the National Cancer Institute has republished
the EPA Report in slightly abridged form in a monograph series
~ under its own logo. By sharp contrast, criticisms of the EPA
Report have qenarally bs.n orchestrated by thee tobacco
industry and have not withstood scientific scrutiny. The
I Draft's oquatinq industry supported criticism of these
critically, reviewed assessments with the assessments
themselves suggests a bias in ths Draft"s development.
~
,
2.
'
~
I
Furthermore, the assessments are all based on a substantial
body_of literature, a fact which the Draft ssams to disregard.
Th.+pr sviQu~, CRS report, cited on CRS-5 as alsq being critical
of 3;':'F~~s analysis, was seriously flawed, aod any citation of
it should be accompanied by a refarenoe to EPA's rebuttal (See
attached letter to Dan Mulhollan). Isn't that why.th, current
Draft is being prepared? Furthermore, the statement in the
footnote that, "It was necessary (for the CRS) to review the
evidence of a passive smoking health risk because this is a
potential component of the cost calculation" is open to
interpretation. As an economic analysis, the previous CRS ~
4 "~
aa
~
ro
~
~
CO

report by Gravalla and Zimmerman went beyond its expertise and
its scop. in reviewing the "evidsnca of a passive smoking
health risk". Since the potential "external" or "spillover"
costs of health effects of ETS are so small compared to the
direct costs of health effects from active smoking, it was
"necessary" only to put a cost value on these "axternals", not
to discuss the uncertainties as the authors saw thes. In
fact, the authors of the previous CRS Report on Cigarette
Taxes discuss fairly extensively the "evidence on passive
smoking [hsalth] effects", but they never discuss the evidence
on the health effects from activa!smokinq, which contribute
far more to the health costs. The question of "why?" is, we
feel, connected to the question of "what is the purpose of
this draft?"
3. The statament that "confounding and smoker misclassification
(ars) the two principle sources of uncertainty in the epi
studias" (CRS-6) again iqnoraa the major downward bias
resulting from exposure misclassification in these studies.
4. On CRS-7, footnote 10, OSHA is part of the Dept. of Labor, not
Energy. The same mistake occurs in footnote 48.
Spideaiologic Studies '
1. On CRS-8, paragraph 3, the Draft reads as if the EPA adjusted
the risk estimates from the individual epidemiology studies
for background ETS exposure. This needs to be clarified. The
EPA did adjust the individual risk estimates for potential
smoker misclassification bias in its hazard idsntification
analysis; however, it did not adjust the individual risk
estimates for "background" bTS wrporurs. uter conducting its
hazard identification analysis, the EPA did adjust the pooled
overall O. S. RR estimate and the overall Pontham at al.(1991)
RR estimate for EPA's two quantjtativs risk analyses.
2. In the section on bias and confounding (CRS-11), it should be
noted that bias and confounding can work in both directions,
and that nondifferential biases exert a downward bias on the
relative risk estimate.
3. The statement (CRS-12) that "EPA adjusted the riskastimates
to account-.,for bias and confoundinq ..." is incorrect. EPA
did axaminrpotantial bias and confounding and concluded that
they could not account for the consistent dosa-rslated
increases in lunq cancar risk observed across numerous studias
from different countries. However, the only adjustment that
EPA mada to the individual relative risk estimates was for the
potential upward bias from smoker misclassification. There is
no consistent evidence that any other upward bias is operative
in thasa apidemioloqic studies, and even the evidence for an
5
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
r3o '
~
oo
_cz
I

I
I
I
I
I
I
I
I
I
I
I
I
i
I
I
I
I
upward bias from smoker misclassification is not conclusive
(Saa discussion of smoker misclassification below).
4. In discussing the consistently increased risks in the highest
exposure groups (CRS-12 to CRS-13), it is misleading to single
out the U.S. studies and contend that only two of these six
were statistically significant without considering the issue
of the low statistical power in most of thesa epidemioloqic
studies, especially when the study population is broken down
into smaller exposure subgroups.
5. In the section on meta-analysis (CRS-13 to CR3-ls), it should
be clarified that the meta-analysis of pooling overall
relative risk estimates by country was only one of several
analyses performed by EPA and that EPA's conclusions do not
rely on the meta-analysis.
6. In the paragraph (CRS-13) discussing the EPA Report's
weighting of the relative risk estimates, the Draft's wording
is very deceptive. it"implies that EPA did something devious
by giving the larger studies more weight. In fact, EPA
weighted the studias by the inverse of the variance, which is
stan$ard statistical methodology. The same deceptive wordinq
was used in the previous CR8 report and was addressed in RPA's
rebuttal (Sea attached letter to Dan Kulhollan, section D.3.).
7. In discussing the pooled relative risk estimate of 1.19 in the
EPA Report from the U.S. data (CRS-13), it should be
emphasized that this is ths pooled estimate for the effects of
spousal smoking, unadjusted for other sources of ETS exposure.
8. The discussion of $PA's use of a one-tailed significance test
is very misleading and slanderous (CRS-13 to CRS-14). A one-
tailed test is a standard statistical procedure when there is
prior evidence that if there is an affect, it is likely to be
in a specific direction. EPA did not "(argue] that there is
no biological reason to expect passive smoking to reduce the
risk of lunq cancar (CRS-14) but, rather, demonstrated that
based on prior knowledge of the carcinogenicity of active
smokinq and the similarities between mainstream saoke and ETS,
any lung cancer affact of BTS would be expected to be
causativa versus protactive. In addition, with respect to the
"crucial point (CRS-14),, where EPA is accused of changinq
tests between drafts, the CRS draft is totally erroneous; EPA
used a one-tailad test in both drafts as well as in the final
report.
Bnvironmentsl Tobacco 3'soke
1. There are more than 40 known or suspected human carcinogens in
STS not just 14 as mentioned on CRS-17.
6
I

I
2. The CR3 draft correctly concludes.(CR,4-lg) that "cigarette-
equivalent exposure estimates vary siqnificantly depending on
which STS component is chosen" and "are probably of liait.d
use in determining risk". Then, three pages later (CRS-22),
the draft contradicts itself and inappropriately suggests that
"typical ETS exposure is equivalent to saokinq approximately
one-tenth of a cigarette every day", based on relative
nicotine levels.
3. The near total reliance on the unpublished Jenkins et al.
study to deteraine ETS exposure represents, at best, a highly
selective and questionable use of available data. This
extensive dependence on a tobacco industry-supported study,
with tobacco industry co-investigators, hardly gives assurance
to EPA and, we suspect, to a great many research scientists,
as well as the public health community, that the CRS, with all
its literature retrieval resources, is interested in an
unbiased analysis.
4. Furthermore the Draftls analysis of the Jenkins .t al. data is
incorrect. Table 3(tR.S-21) is used to show the "average
nicotine concentration and actual nicotine exposure", based on
the recent RJ Reynolds - Oak Ridge (RJR-OR) unpublished 1i
city U.S. study. The implication is that "rssidential anil
other non-workplace exposure tends to exceed workplace
exposure by a factor of 4 to 6" (CRS-2) and (CRS-47), so "that
many workers would not be exposed to sufficient ETS to be at
increased risk for lung caAcer" (CRS-2). However, this
interpretation is incorrect. The correct conclusion to be
derived from results in the RJR-Oak Ridge study is that where
there are no ssaking restrict3ons, 8TS coac.ntrations at boass
and t n the workplaco are siAilar. In soae workplaces, 8TS
levels and average daily exposures are considerably higher
than at hose. This is saen in the enclosed Table which
compares the RJR-OR nicotine concentrations in "hoss" and
"work" settings. The Table also presents estimates of total
daily exposures based on two breathing rat. scenarios: 1) 1.2
al/hr. .( us.d by CRS ), and 2) 10 s3/ 8 hr. at work and 10 as/ 16
hr. at hoa. (sore physiologically realistic).
Caaparison of the two tables highlights several flaws in CRS'
Tablo 3. First, the "non-work" n-548 should not be used as it
includes the n-41s hose and is ;rrdundant and misleading.
Second, the home (n-t1s smoker occupied- hoses) should be
compared with the work n-168 (no smoking restrictions). This
allows direct comparisons in unrestricted saokinq
environments. Third, the exposure comparisons should be made
using the breathinq-rate scenario of 10 m~ for both hose and
workplace (this is what both EPA and OSHk use). Also, weekend
non-work conditions should probably be taken into account.
I
I
I
I
I
I
I
I
I
I
I
I
i
I
I
~
7 IM
~
~
~.
I

ar .. w. w.. .r r i.. .r r+.. r.. .M s+r r a.. en
Table: B'1'S Nicotine C.awaUrations wrd Exposure Pstimata for Smoher-oocupiod Homes versus
Wodcplaoes
Based on Jenkuu et al Data and Various Breadtin,8ltate Aswmptioas'
BNYIRONM6NT NICOTINE AIR
CONCENTRATION (uWm') EXFOSURE (ui/d.y)
at 1.2 m'/hr .t 10 m'/day 6ome ar waic
Home 16 rr MwA at 15 hr x 1.2 m'/hrr st 19 m'/16 hr
(N 4 15) (UN*W-OMpW
boew mly)
me" . 0.68 12.1 6.8
mm 2.16 38.8 21.6
BQq~ ~k 2.79 48.7 27.9
~ 7.10 127 71.0
Wat ~brTwA at t ar x 1.2 m'/hr at 10 ®'/8 br
(N w 520 Toad No Smokiq
Ratriction 1'Lu Sa~oki~ 1~
~ No S~ ~~ $~ ~
no*aod A~ t?~I~/) "
p~~+ R,~pMiriotio~l DodVMod Dedjn~led No Smoking
~~ Atrn Oldy No Snoidq6
SaWmilim Ann Only
Me S Ratricxlons
N s 168
,no" 0.09 0.9 a,P 5.6 0.9 5.8 :
Muuu 0.79 2.77 7.5 26.6 7.9 27.7
IiDt6 por+caWZo 0.48 3.59 ' 4.6 34.5 4.8 35.9
9Sth porawdle 3.90 14.0 37.4 134.4 39.0 140.0
$Re( - SAB CRS: 'ttibb 3: Rqmura .Ad Aitbaps ~x~oeatrukr~ of NbodAO (U.S. )6{.:'!y Study) of
Iodividu.lx Reoordft Tobacao Pioduct
'
'
IUb1a 6, 7, tW t.
l=WMy 1V4?J94,
Ob~lb~ in Airlwa Vam (QIB. CRS-21). RM bM UMMS . OSHA
wlb4 12.4%
Tcol Noatibor ot WakoM SaopMd 1336
z6COBUtoz

i
In addition, note that only 12.4% (168/1356) of tha total
numbar of workplaces samplad by Jenkins at al. had no smoking
restrictions. our recollection is that national surveys
suggest that at least 358 of all U.S. workplaces have no
smoking restrictions. In any event, workplace HTS exposures
are far aore variable than are homa axposur.s. This ia
because of the high variability in workplacs sizes,
ventilation rates and smoker densities. This is sosawhat
apparent in the coaparisons presented in the enclosed Table.
Note that while the aadian cotinina concentrations are higher
for hom: vs. work (0.68 vs. 0.58), the corresponding maans
(2.16 vs. 2.77), 80th percentiles (2.79 vs. 3.58) and 95th
percentiles (7.10 vs. 14.0) are all lower. Thus, even a
blanket statasent of comparability of home vs. workplace
exposures is too precise.
Again, the CRS has depended mainly on the RJR-OR study for its
exposure aatiaatas, and has mada the wrong comparisons. Thara
are many mora (and published) studies availabla.. The CRS
sathodoloqy and primary dependence on this unpublished study
for a conclusion of low workplace axposura should be
corrected.
5. with respect to the discussion of biomarkars (CRS-22), a
compound need not be directly related to a specific health
risk to be a markar of 8TS exposure.
DosQ-Rospons Relationships
1. The EPA Report did not "(assuma] that the entire population of
never saokars was subject to the saas risk" (CRS-24). Rather,
the Report used av.rage, risks, as aatimatad by the
apidamiology studies, to calculate population astisatas, and
different average risks wara used for people with and without
ETS exposure fros spousal smokinq. An alternative could have
been to usa sos. sort of linaar dosa-basad approach, although
there is substantial uncertainty regarding what doses are
associated with what exposures. However, to infer a threshold
froa these apidasioloqy studias, as the Draft has done, is not
justifiable, especially given the exposure misclassification
problams inherent in these studies.
2. On CRS-26, the increased risks observed in the lower exposure
groups of the Stockwall at al. study should not be dismiss.d
as "not statisticallx siqnificant at the 95% confidanca
laval. These small exposure subgroups have low statistical
power and 8'TS is a known human carcinoqanf therefore, the
observed increased risks in these lower exposure groups are
likely to be biologically significant, avan if not
statistically significant.
0
Ct
4h
8 ~
~
~
w
~
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I

I
I
~ 3. Also on CRS-26, it is totally inaccurate to determine that
"the risk values at the lower exposure lavals are all
sufficiently close to unity to conclude that there is a high
~ probability that only the highest exposures to ETS aay present
any risk of developing lung cancer". These studies of spousal
smoking are subject to substantial exposure misclassification
becauss many people are exposed to ETS from a variety of
. sources, not just spouses, and there is no truly "unexposed"
! comparison group. The effects of axposure.aisclassification
would be especially pronounced in a low spousal exposure
_ group, because thase women with low spousal exposures and
I variable other exposures would be compared with women without
spousal exposure but also with variable other exposures. The
high background "noise" from the variable other exposures in
~ both groups is highly likely to mask any sffact of the low
spousal oxposure!
4. The CRS draft ascribes far too auch precision to the relative
~ risks reported for individual subgroups. These are relative
risk eitisatea, based on a crude exposure surrogate, not a
true indicator of total dose; and observed in a small
, subsp.apla of the population. Overall, the study results show
consistent dosa-related increases in lung cancer risk from ETS
exposure. However, the specific estimates should not ba
treated as exact, and the C,RS should not dwell so auch on an
I apparent anomaly in a specific dose-response relationship
(e.g., discussion of Fonthaa et al. results based on total
years of exposure, CRS-26 to CRS-27).
/ 5. Regarding smoker aisElassification bias (CRS-31 to CRS-35}, an
a inherent but unspoken assumption is that former or current
,
!
~
'
,
_
w 6.
,
/
!
sackers are equally likely to be aisclassified as nevar-
saokers whether or not their spouses saoka. Then, it is
explicitly assumed that aisclassified sackers are more likely
to be married to other smokers because smokers tend to marry
other smokers. Howevar, there is no evidence that the first
assumption is accurate. In fact, it seems plausible that
smokers married to other sackers may be less likely to
misrepresent th.aselves as nevar-smokars in self-reports than
sackers married to nonsmokers, who aay faal aore sslf-
conscious and stigmatized about their smoking habit. If this
is the case, then smoker misclassification may not actually
result in any measurable upward bias in thase apideaiologic
studias,~ and may even produce a downward bias.
The CRS analysis of the smoker aisclassification rate required
to eliminate trend in the Fonthaa et al. study (CRS-32 to CRS-
35) relies on an unstated assumption that there is no saoker
misclassification of cases in the baseline comparison group
(i.e., 0 pack-years exposure), vhich may not be warranted. It
apparently also assumes that there is no misclassification in
the control groups, although since.thara are,no accompanying
0
9 ~'
~
~
.~
~
~
.~
I

calculations, we couldn't confirm these fiqures, At the very
least, all these assumptions should be made explicit.
7. The Fontham et al. study was designed specifically to minimize
potential smoker-status misclassification bias.
Kisclassification rates are reported in their paper and
strongly suggest that in their study design, there is no
upward bias due to smoker status misclassification. In fact
they suggest, if anythinq, a small downward bias in their
study. Thus, Table 5 ignores the available data in order to
hypothesize a "what if" scenario.
8. With respect to the "second question" raised at the bottom of
CRS-33, i.e., "whether there is reason to believe that the
(saoker] misclassification rate would be higher for those most
intensively exposed", such speculation is counterintuitive.
3mokinq women whose spouses snoke a lot are more likely to
smoke a lot themselves and less likely to be misclassified as
never-ssokers. It is generally former smokers and occasional
current smokers that are misclassified (about 20), not
heavier current smokers (about lt) (See EPA Report, Appendix
B) . _
9. Also, see again the comments above on smoker-status
misclassification rates necessary to account for the observed
increasas in Japan and Greece (General Comments #3).
BTS and Lung Cancer Deaths
1. On CRS-35, "backqround" ETS exposure needs to be defined so
that it is clear that this refers to all sources of exposure
(e.g., work, social settings, etc.) other than the spouse.
2. On CRS-36, in discussinq the approach used by EPA to estimate
the population risk, it should be noted that EPA used two
approaches, one based on the pooled estimate for the II.S.
studies and the other based on the results of the Fontham et
al. (1991) study.
3. On CRS-37, CSS claims that "in essence, background ETS,
accordinq.to the =PA and NRC calculations at least, appears to
be considerably aoree potent than spousal BTS". The difference
in.amount of risk from spousal versus background ETS reflects
differences in amount of exposure, not potency. Claiming one
source of ITS is more- "potent" than another suQQests that
there are differences in risk from the same amounts of ETS
generated from different sourcea. Furthermore, som. of EPA's
calculations (based on the Fonthas et al. study; See EPA
report, page 6-23) found the same risk or greater risk from
spousal exposure as from background STS. Similarly, the NRC
calculations estimate more risk from spousal than from
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
r~ -
10 ~
~
. ~
~
~
I

I
I
I
.
I
I
I
5.
I
I
6.
I
I
I
I
.
I
I
I
8.
I
I
I
background sources of ETS, contrary to what the CRS draft
suggests.
Also on CRS-37, the CRS draft claims that "EPA assumes that
atter a certain point, the risk of ETS becomes greater to
these individuals than the risk due to having smoked". This
statement is incorrect. The ETS risk to tormer smokers is not
necessarily greater than the risk from having smoked, but it
is greater than if they were not involuntarily exposed and it
becomes relatively more significant compared to the
"voluntary" risk they assumed from previously smoking.
On CRS-38, CRS claims that "the (LCMRJ method just described
is exactly equivalent to assuming that the values of relative
risk... are the sase...". This statement is false. ' As
groups, both former smokers and male never-smokers have
greater background risks of lung cancer than female never-
smokers; therefore, it.they have the same ETS exposures and
risks (LClQts) as femala never-smokers, they would have lower,
not the same, relative risks.
On CRS-38, it is illogical to claim that SP71 assumed that all
of the never and long ago former smokers who have been expos?~si
to spousal smoking have been subjected, on a.eraqe, to ths
same combined level of spousal and background sTS, and all
never and long ago former smokers not exposed to spousal ETS,
received, on averaQe, the same amount of background ETS
(emphasis added)". If the point is that never and former
smokers were assumed to be exposed to th. same average Lveli,
then the issue of dose-response in the remainder of the
paragraph does not follow. It appears, rather, that CRS is
trying to suggest that EPA assumed everyone was exposed to the
same level rather than an average level (See also comment #1
in the Dose-Response Relationships section).
Also on CRS-38, CRS states "that the risk only becomes
maasurable after a long term, intense exposure to ETS
(emphasis added)". "lieasurable" is a critical concept given
the imprecise nature of the epidemioloqic studies and the
absence of a truly "unexposed" group (See comment #3 in the
Dose-Response Relationships section). CRS then ignores these
issues and assumes that there is no risk at exposure levels
below those for which the risk becomes measurable.
CRS tbenAclaims that fthe number of non smokers ... who are'
exposed to levels of ETS... extensive enough to be at a
significant risk of developing lung cancer is likely to be
considerably smaller than that entire non smoking population
(as was assumed by EPA and NRC)" (CRS-38). cRS does not
define "significant risk". If EPA had done a dose-based
quantitative risk assessment, people exposed to lower than
average ETS levels would, in general, have lower than average
11

I
risks; however, this would be offset by people with above
average exposures having above average risks.
9. The suggestion that "the 13!" with the highest ETS exposure is
at "at least 20 times" greater risk based on coaparinq
unadjusted RRs of 1.42 and 1.02 from two different exposure
levels (CRS-39) again ascribes too much precision to the
specific rasulta of a single epidasioloqic study. The
comparison also suffers from the use of the unadjusted RRs
rather than the adjusted RRs.
10. Furthermore, the 13% of the Pontham et al. controls exposed to
40 or more pack-years of spousal smoking may not represent the
entire adult U.S. nevarsmoking population. The controls were
selected to match the cases on aqe and race; they ware not
selected as a random population sample.
11. The Riboli at al. 10-country results may not reflect exposures
in the o.S. .
12. On CRS-40, paragraph 1, it is unclear why CRS switches from
discussing the "13:" exposed to 40 or more pack-years (CitS-39)-
to the "4%" exposed to 80 or more. It does not follow that
"it is probable that only 2 percent of the background only
group was subjected to $TS' exposure amounting to the
equivalent of 40 pack-years"; half of 13% would be 6.5% by
these calculations.
13. On CRS-40, paragraph 3, CR4 repeats its mistaken assertion
that the LC'!at method "is equivalent to assuminq that the
relative risks from ETS for [aale never saokers and long ago
former smokersj is exactly the same as for female never
smokers". See comment #5 above.
14. The "threshold" methodology proposed on CRS-41 for estimating
lunq cancer deaths from ETS is seriously flawed. As described
above, the apidemioloqic studies are not sufficiently pracise
and suffar from exposurs misclassification; therefore, there
is no sound foundation for assuminq that a threshold (or
abruptly sublin.ar exposura-rasponsa curve) exists for
exposure levels of practical concern (See comment #3 in the
Dose-Response Ralationships'section).
15. In addition, thsre is no sensible scientific basis for
assuming a"thrashold"-for a carcinogenic agent that has both
initiating and promoting capabilities and has demonstrated its
carcinogenic potential at typical environmental exposure
levals. The concept of ascribing a practical threshold to low
levels of exposure say have some merit when extrapolating
from, say, high occupational to low environmental levels of
exposure, which typically range over a factor of 100 to 1,000
times. It is much sor* problematical when the factor from
12
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I

a
I
~
'
.
, 16.
~
~
i
'
,
/
.
'
-
-!
.
r
,
17.
!
lower to higher is 2 to 3 times, and there is a damonstrated
downward bias operating in addition. While the Draft does try
to make that argument, we feel that it lacks logic.
Considerinq how quick the Draft is to adopt uncertainties
regarding unspecified confounders (especially for heart
disease and ETS) as a rationale for rejecting observed
associations, it is hard to understand how the threshold
concept becomes so uncritically embraced.
Furthermore, even if a"threshold" were assumed to exist, the
methodology used by CRS leaves no marqin for human variability
or saasuremant error. For exaaple, applying the EPA method
for deriving reference doses (i.s., an estimate of the daily
exposure to the human population, including sensitive
subgroups, that is likely to be without an appreciable risk of
deleterious effects during a lifetime; see attached reference
by Barnes and Dourson) for noncarcinoqenic agents, which are
presumed to have exposure thresholds for inducing
noncarcinoqanic effects, to the exposurs-response results
based on pack-years of spousal exposure from the lonthas et
al. study miqht proceed as follows: The 15.1-39.9 pack-year
exposure group (OR-1.02) siqht be considered a"no observable
adverse effect leval, or NOARL, while the 40.0-79.9
(OR-1.34) would be considered a"lowest observable adv~
rs4
effect level", or i.ZA8L. These levels are sensitive to the
specific cut-points u..d and to the statistical power of the
study to detect an effect in the exposure groups.- For
example, a significant increase aay have be.a observable in
the lower exposure groups if the sample size had been greater
or in a 30-50 pack-year group if different cut-points had been
used. In the absence of a NOAZL, the LOAEL is used with an
uncertainty factor of 10, because of the uncertainty as to
where the threshold may lie. In this study, the NOaEL of
15.1-39.9 would be usQd. Then an uncertainty factor of 10
would be applied for interindividual variability within the
human population, to allo;r a margin of safety to protect more
sensitive subpopulations. Finally, a sodifyinq factor of 2-10
siqht be applied to take into account the fact that lung
cancer is a serious, generally fatal, health effect, as
oppos.d to moderate changes in body weiqht, for exaaple. So,
even if a threshold were assumed (which is not appropriate in
the cass of ETSI), a sore responsible analysis would not
assume that a"safe" axposure level exists abovs that which
results in the dose received by the 15-40 pack-year group
divided by 20-1001 -
If the purpose of the CRS quantitative risk calculations is to
distinguish between spousal and nonspousal exposures, the lung
cancer deaths in nonsmokers exposed to spousal smoking should
be broken down into thoss LCD's attributable to the spousal
saokinq and those attributable to other sources of ETS (CRS-42
to CRS-43). As it is now, the Table (CRS-42) could be N
CZ1
13 ~
t.~
~
~
~
I

misinterpreted as suggesting that all the LCD,,s in the
spousally-exposed group are from spousal smoking.
Occupat.ional S'TS Lunq Cancer JUsk
1. On C8S-43, CRS claims, with respect to quantitative risk
assessment, that "EPA sade no attempt to assess the lung
cancer risk from occupational (i.e., workplace) exposure to
ETS, arguing that there are too few workplace ETS studies to
conduct a aeta-analysis, and that it is difficult to obtain
reliable assessments of workplace ETS exposure". In fact, EPA
did not quantitatively assess the lung cancer risk from
occupational exposure to ETS because it was beyond the scope
of EPA's risk assessment. EPA does believe that the workplace
lung cancer results are generally unreliable and should not be
used in a aata-analysis. If EPA had done a workplace risk
assessaant, the Agency most likely would have used the Fonthaa
st al. occupational results, because the Fonthaa .t al. study
is th. highest quality.study and it is a large multi-regional
U.S. study. EPA did use the Fonthaa et al. (1991) results for
one of its population risk calculations.
2. On CRS-44, last paragraph, it is not legitimate to claim that
"only one of these was well-conducted, according to EPA". Spl1
categorized the biqhst quality (for th. purposes of obtaining
information on BTS) studies in "Tier 1"i however, EPA's
categorization does not assert that studies in lower tiers
ware not "w.ll-conductul".
3. On CRS-45, with respect to the Srownson et ai. occupational
results, it is worth noting that lung cancer risks were
increased in the two highest exposure quartiles.
4. On CRS-45, CRS cites the results of the Lavois and Layard
workplace aeta-analysis. There are, however, serious probleas
with this analysis. Please sea the attached paper, "Passive
smoking and lung cancer: the U.S. EPVs weight-ot-evidenca
analysis, with emphasis on the epidemiology studies.
5. On CRS-47, the Riboli et al. results aay, not be applicable to
the U.S.
6. The statements on CRS-47 starting with "Stropq evidence ----"
and anding with "These data suggest that the+workplace is not
the dominant place of exposure and that workplace and
residential exposures aay not be comparable" ar. all, at best,
insupportable by the Draft's analysis of the Jenkins study, as
detailed above. We suggest that a such better exposure
analysis is needed, not only of the Jenkins et al study; but
of the many other exposure studies. See also the coaaents
above on exposure.
14
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I

a
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
7. The conclusion that "I!, on averaqe, workplace ETS exposure is
lower than residential exposure, then it is likely that aost,
if not all, workers would not be exposed to sufficient levels
of bTS to be at increased risk tor lung cancer" is not
warranted in any event. Even if high exposure levels were
required to develop lung cancer, and even if avarage workplace
levels were lower than average residential levels, there are
a substantial nusber of workers, especially in the hospitality
industries and in other workplaces with no smoking
restrictions, that are exposed to very high levels of ETS.
8. The linal sentence, claiainq "The evidence ... casts
doubt on OSHA's risk assessment and suggests that it say
have siqnilicantly overestisated the occupational 8T3
lung cancer risk", is just not supported by the Dralt"s
analysis.
Apportdiz A
1. This presentation oi the EPA's conclusions about the
respiratory health effects of passive smoking should include
the Agency's conclusion that BTS is a known huaan carcinoqen,
because this classification conveys the co:.clusion of a causrl,
association and the strength of the evidence supporting this
conclusion.
Appendix B
1. Appendix B is Aisleadinq. It should state aore explicitly and
immediately that this extrapolation illustrated lroa active to
passive smoking pertains to the cigarette equivalent approach,
and it should clarify that this was not the sethodology
employ.d by the =PJ1.
2. The illustration ostits the possibility of a supralinsar dose-
response relationship, which, incidentally, is likely to be
the appropriate extrapolation lroa high to low doses of
tobacco ssoks for cardiovascular risk (See coaunts on
Appendix C below).
Appendix C
1. The stateaant (pq. cR8-51) that "Whereas the EPA estisate of
passive smoking lung cancer deaths used a value of Z-1.75,
Wells ahose a higher value of Z-2.6, based on Fonthas"s study
..." is inaccurate. The EPA derived its estiaate using two
different approaches, one of which eaployed Z values of 2.0
and 3.6 obtained troa the Fonthas study (See the EPA report
pages 6-21 to 6-26).
2. The coaparison of an active smoking h.art disease risk of 1.7
with'a passive saokinq heart disease risk of 1.22 is flawed by
15
I

oversimplification. For one thinq,'studias of active smoking
use navar-s=okars (including those exposed to ETS) as the
baseline camparison group, while studies of STS use
"unaxposad" navar-smokars as the comparison group; therefore,
these relative risks are not directly comparable. In
addition, because heart disease risk drops dramatically upon
smoking cessation, a more raasonable comparison would be to
compare the risks for current active smokers to those for
current passive ssokers. Furthermore, the summary age-
adjusted relative risk of 1.7 for heart dis.asa from ever
smoking obscures the much larger aqe-specific relative risks
from smoking observed in younger aqa groups (Saa, a.q., The
B.alth Consequenc.s of 8moklnq:. Card.iovaicular Dissse, U.S.
DIDiS, 1983, pqs. 103 and 113-115, and the recent study of
Parish at al., 1995, Bi6T 311:471-7, which reports risk ratios
for nonfatal myocardial infarction for current saokers vs.
nonsmokers of 6.3 for 30-39 year-olds, 4.7 for 40-49, 3.1 for
50-59, 2.5 for 60-69, and 1.9 for 70-79.). Also, more recent
studies of active saol4inq are reporting higher RRs for heart
disease than earlier studias, apparently as a result of
decreasing baseline risks for heart disease dua to recent
lifestyle changes such as better diets and exercise. If these
issues wara taken into account, the diffarence in RRs betwaeS
active and passive smoking wouid be larger.
3. Furthermore, the CRS analysis does not satisfactorily present
the possibility that a supralinear dose-response relationship
exists between active and passive saokers with respect to CVD
risk, i.e., that some of the effects of tobacco smoke on the
cardiovascular system saturate at higher doses. The CRS draft
does not discuss the mechanistic evidance supporting this
hypothesis. For example, platelet activation appears to
saturate at low doses of tobacco smoke, and nonsmokers appear
to be more sensitive than smokers to tobacco smoke-induced
andothelial damaqa (S.a Glants and Paralay, 1995, JA1i71
273:1047-1053).
See also the recent studies of willett at al. (1987, N8J1t
317:1303-1309) and Palmer at al. (1989, NEJK 320:1569-1573),
which both report statistically significant relative risks of
about 2.4 in the groups that smoked only 1-4 ciq/day.
4. The CRS draft should discuss more fully the mechanistic
videnca that ZTS causes cardiovascular ef~ects.(See Glants
and Parsley, 1995). For sxampla,'thars is strong avidence
that ETS promotes the development of atherosclerosis, a major
cause of heart disease. Animali models have shovn that
subchronic exposures to low levels of ETS promote the
development of atherosclerosis, and there is human evidence
that ETS exposure increases the carotid artary vall thickness,
suggesting that 8'TS also contributes to the development of
atherosclerosis in humans.- The role of ETS in atheroqanesis
r.~
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
_'

I
I
I
I
I
r
r
5.
.,
,
i 6.
'
,
,
~
~
~
~
,
~
,
I
is likely mediated, at least in part, by polycyclic aromatic
hydrocarbons (PkBs). A recent biomarkar study suggests that
passive smokers receive up to 40% of the PA8 dose of active
smokers (Crawford at al., 1994, JNCI 86:1398-1402). The
sachanistic evidence that ETS can create an isbalance.b.twean
oxyqin supply and desand, as revealed by decreased exercise
tolerance, and can activate platelets similarly warrants sore
discussion.
Other machanistic evidence is oiitted from the CRS draft
altogether (See Glants and Parsley, 1995). For axample,
anisal studies have deaonstrated that STS decreases the
ability of the styocardius to process oxygen to produce ATP for
energy and that ETS exacerbates ischeaia/reparfusion injury.
The CRS draft suggests that "one cannot rule out the
possibility that the heart disease risk values in ths api
studies may be largely due to confoundinq", but presents no
evidence that confoundinq is affecting the apidemioloqy
results. The draft claiss that nonsmokinq spouses of smokars
are likely to share soma of the unhealthy lifestyle
characteristics -qenarally associated with their ssoking
spouaas, but again presents no evidence that this explains any
of the epide'ioloqy results.
Zn the discussion of contoundinq in the lung cancer section
(paqes CRS-27 to CRB-31), it is noted that Le Marchand (1991)
reported decreasing cholesterol and total fat consuaption with
incraasinq ETS exposure, while Alavanja at al. (1993) found no
correlation between saturated fat intake and exposure to ETS.
Fonthaa et al. (1994) reported an increased risk of lung
cancer associated with dietary cholestarol, but their lung
cancer results from sTS exposure were not affected by dietary
cholesterol, similarly suqqestinq no correlation between
dietary cholesterol intake and exposure to STS.' Both
cholesterol and fat consuicption are risk factors for CVD. The
CRS draft also cites. Friedman at al. (1963) as raportinq a
correlation between 8TS exposure and alcohol consumption.
Moderate alcohol consusption is generally considered to be
protective aqainst CVD. These results, presented by the CRS,
suqqest that these "potential confoundinq factors" ari either
not associated with ETS exposure or say actually be exerting
a downward blas on the relative risk estimates for CVD.
The CRS draft notes that only 4 of 12 epidasioloqy studies
controlled for at least 6 potential confounders and that the
largest study failed to control for any of thes (although it
did, in fact, attempt to control for SES by adjusting for
education and quality of housing). Six is not a maqic nusbar,
and not all of the potential confounders are equally
important. Roughly half of the itudies controlled for at
least the major CVD risk factors of hypertension, cholesterol, ~~
~
17 ~`
Co
Pr
~

I
l
and obesity. In addition, Wells (1994) observed that the
relative risk estiaates of studies that adjusted for the aost
factors were generally higher, indicating that the net effect
of any confounding in these studies say be to bias the risk
estisates downward.
While potential confounding can never be ruled out, a thorough
review of the epideaiology studies suggests that it is highly
unlikely that the observed increases in CVD risk from ETS
exposure are due to confounding. The aajority of studies
controlled for at least the major CVD risk factors, and there
is a strong consistency of results across different studies
from different countries with different lifestyles and diets.
Furthermore, a number of studies reported positive dose-
response relationships, which are difficult to explain in
terms of confounding.
7. Even if the Draft's review were an accurate representation of
the available data .and even if its superficial and
hypothetical concerns about the reported risks were more
convincing, the Draft's conclusion that "the ETS heart disease
wholl
risk should probably be viewed with soae skepticisa" isl
inadequate in view of the potential magnitude of the healt~
risk. k sore appropriate conclusion would be "Because of the
known causal association between activ. smoking and CVD,
observed even at the lowest doses, the increased risks of CVD
from STS exposure consistently observed in epidemiology
studies, and the mechanistic data demonstrating cardiovascular
effects from low exposures to tobacco smoke,- and because of
the potential for substantial morbidity and aortality, the ETS
heart disease risk should be viewed with eztreae concernl"
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
